MedPath

A prospective investigation of the association between GALAD score and the features and survival of hepatocellular carcinoma.

Completed
Conditions
To identify correlation between the GALAD score and tumor feature, HCC staging and patient survival.
Hepatocellular carcinoma , GALAD , tumor feature , Survival, HCC staging
Registration Number
TCTR20230312003
Lead Sponsor
avamindradhiraj University Research Fund
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
115
Inclusion Criteria

Participants must be at least 18 years with first diagnosed HCC base on Barcelona Clinical Liver Cancer (BCLC)

Exclusion Criteria

Other primary liver malignancy or liver metastasis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
relationship between GALAD and HCC feature and survival 6 months tumor characteristic, survival
Secondary Outcome Measures
NameTimeMethod
relationship between tumor marker and HCC characteristic and staging of HCC at the beginning of study characteristic of HCC, staging of HCC
© Copyright 2025. All Rights Reserved by MedPath